Locations:
Search IconSearch
December 3, 2021/Pediatrics/Neurosurgery

Study Examines Outcomes of ‘Ultra Early’ Epilepsy Surgery

Cleveland Clinic authors contribute to large epilespy surgery study

21-CHP-2529943 CQD 650×450

Drug-resistant epilepsy (DRE) is often a devastating disease when it begins in infancy.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

While some infants are surgical candidates for brain surgery, which can be a life-altering intervention, most are not referred to a specialized center in time. This is due to a myriad of reasons, including lack of education about options, access, fear of brain surgery, and fruitless anti-seizure poly-therapy trials.

A delay in treatment often leads to epileptic encephalopathy with loss of critical developmental window in an infant’s development. The authors of a new study, published in Epilepsia, set out to review the safety and efficacy of “ultra-early” epilepsy surgery. Ajay Gupta, MD, Section Head of Pediatric Epilepsy at Cleveland Clinic Children’s, is a coauthor on this study.

Findings: At a glance

In this multicenter and multinational collaboration, the authors demonstrated safety and efficacy of epilepsy surgery in the youngest children, infants < 3 months of age. The study shows that epilepsy surgery was not only the most effective treatment leading to seizure remission in 66% of the infants with DRE but also it was safe in the hands of experienced surgeons and dedicated centers with no death or major unexpected long-term morbidity.

Cleveland Clinic’s Pediatric Epilepsy program

Cleveland Clinic’s Pediatric Epilepsy program contributed one of the largest cohorts in this paper as a result of the highly specialized, experienced and collaborative care across pediatric epilepsy, neurosurgery, intensive care, anesthesia, and pediatric subspecialty consultation teams that are critical to good outcomes in this sick and vulnerable patient population.

Advertisement

Reference

Roth J, Constantini S, Ekstein M, Weiner HL, Tripathi M, Chandra PS, Cossu M, Rizzi M, Bollo RJ, Machado HR, Santos MV, Keating RF, Oluigbo CO, Rutka JT, Drake JM, Jallo GI, Shimony N, Treiber JM, Consales A, Mangano FT, Wisoff JH, Teresa Hidalgo E, Bingaman WE, Gupta A, Erdemir G, Sundar SJ, Benifla M, Shapira V, Lam SK, Fallah A, Maniquis CAB, Tisdall M, Chari A, Cinalli G, Blount JP, Dorfmüller G, Christine Bulteau, Uliel-Sibony S. Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study. Epilepsia. 2021 Aug;62(8):1897-1906. doi: 10.1111/epi.16959. Epub 2021 Jun 14. PMID: 34128544.

Advertisement

Related Articles

abstract image of clinicians walking quickly

How Pediatric Residency Changes May Reshape the Hospital Medicine Workforce

Survey and focus group findings highlight key concerns among PHM leaders

Man in blue suit talking to man in white coat
August 28, 2026/Pediatrics/Cardiac Surgery

Using CT to Prevent Heart Block After Congenital Aortic Valve Surgery

Surgeons can estimate the location of conduction tissue they cannot see

Clinician with child at table

Improving Time to Evaluation in Autism Spectrum Disorder

Pilot program addresses extended wait times for evaluation

Surgeons in operating room performing heart transplant
August 24, 2026/Pediatrics/Cardiac Surgery

Peak Donor Troponin May Matter More Than Troponin Trends in Pediatric Heart Transplant

Practice implications for donor selection and timing

mom holds phone for telehealth appointment
August 21, 2026/Pediatrics/Neonatology

How Cleveland Clinic Is Transforming the Transition From NICU to Home

Early data show improved rates of breastfeeding support, reduced healthcare utilization

sickled blood cells with DNA double helix

Words Matter When Counseling Patients About Sickle Cell Gene Therapy

Helping families understand what treatment can and cannot change

Dr. Kim with a patient

Therapeutic Drug Monitoring in Pediatric IBD: Symptom Management Is No Longer Enough

Why it's a key strategy to optimize biologic therapies and improve outcomes in pediatric IBD

teen sitting in bathroom with phone

When Pediatric GI Symptoms Need Both Gastroenterology and Psychology

An integrated approach to care

Ad